CSMYF Balance Sheet - Cosmos Pharmaceutical Corp

Watchlist Manager

Watchlist

Price: 48.271 USD -21.37% Market Closed

Market Cap: $3.9B

Metric	FY2017 May 2017	FY2018 May 2018	FY2019 May 2019	FY2020 May 2020	FY2021 May 2021	FY2022 May 2022	FY2023 May 2023	FY2024 May 2024	FY2025 May 2025	FY2026 May 2026
Cash & Cash Equivalents	27.7B	21.7B	19B	52.1B	55.1B	37.4B	45.9B	52.3B	57B	61.3B
Cash Equivalents	27.7B	21.7B	19B	52.1B	55.1B	37.4B	45.9B	52.3B	57B	61.3B
Total Receivables	3.4B	4.6B	5.7B	5.9B	6.6B	8.6B	10.2B	12.2B	12.2B	20.2B
Accounts Receivables	22m	91m	398m	108m	100m	198m	452m	637m	761m	889m
Other Receivables	3.4B	4.5B	5.3B	5.8B	6.5B	8.4B	9.8B	11.6B	11.5B	19.3B
Inventory	40B	48.7B	53.3B	53.6B	60.5B	66.4B	77.5B	86.2B	92.3B	99B
Other Current Assets	2.6B	2.3B	2.4B	2.6B	2.8B	3.2B	3.5B	3.7B	4B	4.4B
Total Current Assets	73.7B	77.3B	80.4B	114.2B	125.1B	115.5B	137.1B	154.3B	165.6B	184.9B
PP&E Net	134.5B	154B	172.8B	185.4B	195.1B	225.3B	259.5B	295.8B	331.1B	380.9B
PP&E Gross	134.5B	154B	172.8B	185.4B	195.1B	225.3B	259.5B	295.8B	331.1B	380.9B
Accumulated Depreciation	(43.2B)	(53.3B)	(63.3B)	(73.9B)	(84.4B)	(96.7B)	(109.9B)	(126.3B)	(144.4B)	(164.7B)
Intangible Assets	215m	295m	287m	268m	326m	433m	547m	497m	446m	933m
Long-Term Investments	4m	5m	4m	5m	5m	4m	4m	4m	4m	3m
Other Long-Term Assets	17.3B	19B	20.1B	20.5B	20.7B	21.9B	23.9B	25.9B	27.6B	29.7B
Total Assets	225.7B	250.6B	273.6B	320.3B	341.3B	363.1B	421B	476.5B	524.8B	596.5B
Accounts Payable	91.7B	105.1B	110.8B	136.5B	133B	139.2B	161.9B	179.5B	177.1B	195.8B
Accrued Liabilities	5.4B	5.1B	5.8B	8.1B	7.5B	6.5B	8.5B	10.1B	13.4B	13.2B
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	6.3B	5B	3.2B	3.1B	3.1B	3.1B	4.5B	6.5B	7.9B	11.3B
Other Current Liabilities	10.7B	11.3B	13.4B	14.2B	15.9B	13.3B	17.2B	17.1B	22.2B	20.6B
Deferred Revenue	—	—	—	—	—	350m	519m	522m	380m	518m
Total Current Liabilities	114.1B	126.4B	133.2B	162B	159.5B	162.1B	192.1B	213.2B	220.7B	240.9B
Long-Term Debt	15.5B	12.2B	10.7B	9B	7.3B	6.4B	13.7B	27.6B	42B	67.2B
Other Liabilities	3B	3.1B	3.4B	3.6B	3.9B	4.1B	4.1B	4.3B	4.6B	4.7B
Total Liabilities	132.6B	141.7B	147.3B	174.6B	170.7B	172.5B	209.9B	245.1B	267.3B	312.8B
Common Stock	4.2B	4.2B	4.2B	4.2B	4.2B	4.2B	4.2B	4.2B	4.2B	4.2B
Retained Earnings	84.6B	100.4B	117.8B	137.2B	162.1B	182B	202.5B	222.3B	248.3B	274.4B
Additional Paid In Capital	4.6B	4.6B	4.6B	4.6B	4.6B	4.6B	4.6B	5.1B	5.1B	5.1B
Unrealized Security Profit/Loss	1m	1m	1m	1m	1m	1m	1m	1m	1m	0
Treasury Stock	(238m)	(238m)	(238m)	(238m)	(238m)	(241m)	(242m)	(225m)	(227m)	(227m)
Other Equity	(73m)	(89m)	(91m)	(61m)	(38m)	5m	40m	103m	101m	237m
Total Equity	93.1B	108.9B	126.3B	145.7B	170.6B	190.5B	211.1B	231.4B	257.5B	283.7B
Total Liabilities & Equity	225.7B	250.6B	273.6B	320.3B	341.3B	363.1B	421B	476.5B	524.8B	596.5B
Common Shares Outstanding	39.6m	39.6m	39.6m	39.6m	39.6m	79.2m	79.2m	79.3m	79.3m	79.3m